Headlands Research Announces Partnership with Sahara Behavioral Health
January 5, 2024 – Clinical Trials – Headlands Research, Sahara Behavioral Health, clinical trials
The collaboration improves access to clinical research and investigational treatments while supporting participant recruitment efforts in Arizona
4 January 2024 — California, US — Headlands Research, a leading multinational network of clinical trial sites, today announced a partnership with Sahara Behavioral Health to improve the accessibility of clinical research and investigational therapies for those seeking psychiatric and addiction care in Arizona, US.
“Partnering with Sahara Behavioral Health draws on our extensive experience in psychiatric trials and emphasises our commitment to expanding clinical trial access,” said Kyle Burtnett, CEO of Headlands Research. “This relationship is a win for all involved – for sponsors looking to conduct research in Arizona, for providers searching for more treatment options, and most importantly, for local people seeking positive mental health outcomes.”
Headlands Research specialises in large-volume recruitment and retention of diverse, inclusive and specialty populations while delivering the highest quality data. The network relies on expert clinical researchers and renowned key opinion leaders who prioritise the participant experience. Through community and physician partnerships, a broad range of therapeutic expertise and a commitment to advancing innovative medical therapies, Headlands Research aims to make clinical research accessible to all individuals.
Sahara Behavioral Health offers a diverse range of services designed to treat children, adolescents, adults and seniors with conditions such as depression, anxiety, substance abuse, ADHD, PTSD and more. With several locations across Arizona, Sahara Behavioral Health prioritises compassionate, accessible and culturally inclusive care.
“At Sahara Behavioral Health, we are committed to our patients, profession and community; commitments we believe align with the values and mission of Headlands Research,” said Dr Satinder Purewal, medical director of Psychiatry and founder of Sahara Behavioral Health. “Together, our organisations create many opportunities for improved outcomes for patients seeking mental health and addiction treatment.”
About Headlands Research
Headlands Research is a multinational integrated clinical trial site organisation with a mission to improve lives by advancing innovative medical therapies. Its network of sites focuses on large-volume recruitment and retention of diverse, inclusive and specialty populations while delivering the highest quality data. Headland Research’s principal investigators and KOLs are proven experts in a broad range of therapeutic areas. To date, Headlands Research has successfully supported more than 5,000 clinical trials. For more information, visit www.headlandsresearch.com.
About Sahara Behavioral Health
At Sahara Behavioral Health, our mission is to improve lives by providing compassionate, effective mental health and addiction services to our community. Our treatment approaches are individualised to each patient’s unique needs. We serve patients through all stages of life, including children, adolescents, adults and seniors. We take pride in offering our patients the highest standard-of-care with a comprehensive approach that includes assessment and diagnosis, medication management and treatment services. Sahara Behavioral Health offers in-person or tele-video appointments and has six locations across Arizona in Anthem, Chandler, Glendale, Peoria, Surprise and Tucson, all US. In addition to medication management, we provide in-office treatments, including Esketamine, Ketamine and transcranial magnetic stimulation (TMS). Visit: saharabehavioralhealth.com.
